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Abstract 
The status of the platelet-derived growth factor (PDGF) receptor in normal rat kidney (NRK) fibroblasts and in NRK fibroblasts 
transformed by the v-src oncogene or the polyoma middle T (pmt) antigen has been compared, v-s rc -NRK cells have 7-fold fewer surface 
binding sites for PDGF than NRK cells, but the affinity of the residual receptors for PDGF is reduced only 2-fold. Levels of the PDGF 
receptor measured by Western blotting or in an autophosphorylation assay in vitro are 8- and 4-fold lower respectively in v-s rc -NRK cells 
than in NRK cells. No PDGF-induced phosphorylation f the PDGF receptor is apparent after 32p-labelling of intact v-s rc -NRK cells, 
implying that he reduction in PDGF receptor levels is not a consequence of production of autocrine PDGF. A 10-fold reduction in the 
amount of mRNA for the PDGF receptor is also observed in v-s rc -NRK cells. No decrease inPDGF receptor protein or mRNA levels is 
observed in pmt-NRK cells. We conclude that levels of the PDGF receptor in v-src-transformed NRK fibroblasts are modulated by 
reduction in the level of PDGF receptor mRNA. 
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I. Introduction 
Transformation by viral oncogenes frequently results in 
a profound reduction in the binding of growth factors to 
their receptors on the cell surface [1,2]. Two common 
mechanisms by which these effects are achieved are a 
reduction in receptor mRNA [3], or autocrine production of 
growth factor [1,2]. In the latter case internalization of 
occupied receptor leads to subsequent intracellular degra- 
dation, and hence to a reduction in the number of cell 
surface binding sites. 
Down-regulation of EGF receptor mRNA has been 
observed previously following transformation by the v-s rc  
oncogene. Infection of normal rat kidney (NRK) [4] or 
Rat-1 [5] fibroblasts with a retrovirus carrying a tempera- 
ture-sensitive v-s rc  oncogene resulted in a greater than 
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90% reduction in the numbers of EGF receptors at the 
permissive temperature, with no apparent change in recep- 
tor affinity [4]. Although other workers have reported that 
mouse 3T3 fibroblasts transformed by a temperature-sensi- 
tive v-s rc  oncogene showed a 10-fold reduction in EGF 
receptor affinity at the permissive temperature, with no 
apparent change in receptor number [6], Northern blotting 
experiments were consistent with a reduction in EGF 
receptor levels since a significant reduction in the amounts 
of EGF receptor mRNA was observed following v-s rc  
induction [3]. Modulation of the PDGF receptor at the 
RNA level following v-s rc  transformation has not been 
reported previously. 
Autocrine growth factor production has been observed 
in many fibroblast cell lines generated by transformation 
with viral oncogenes other than v-src .  Secretion of trans- 
forming growth factor-t~ (TGF-cO, an EGF homologue 
which binds to the EGF receptor, resulted in increased 
receptor internalization and degradation [1]. Fibroblasts 
transformed by SV40 virus, adenovirus, Kirsten and 
Moloney murine sarcoma viruses or simian sarcoma virus 
secreted a PDGF-Iike molecule into the medium with a 
resultant 50-100% decrease in PDGF receptor levels [2]. 
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Although the v-src oncogene was not tested in these 
experiments [2], Weber and co-workers observed no alter- 
ation in binding of PDGF to v-src-transformed Rat-1 
fibroblasts [3]. The observation that PDGF-induced c-los 
expression i v-src-transformed mouse 3T3 fibroblasts was 
still 60% of the level observed in untransformed cells [7] 
also suggested that v-src transformation did not reduce 
PDGF receptor levels by more than 40%. 
A third distinct mechanism for down-regulation of 
PDGF receptor signalling was observed in mouse fibrob- 
lasts transformed by the v-ras oncogene. These cells ex- 
pressed normal levels of PDGF receptor as measured by 
Western blotting [8], or by binding of iodinated PDGF [9], 
but PDGF-dependent receptor autophosphorylation was 
profoundly suppressed by an inhibitory factor present in 
the cell membranes [8] with a consequent attenuation i  
downstream signalling [9,10]. 
During a study of the effects of PDGF on the associa- 
tion between phosphatidylinositol 3-kinase and the PDGF 
receptor, we noticed that PDGF-dependent autophospho- 
rylation of the PDGF receptor was profoundly suppressed 
in v-src-transformed NRK fibroblasts [11]. We therefore 
investigated the levels of PDGF receptor protein and its 
associated tyrosine kinase activity in these cells, and in 
NRK fibroblasts transformed by the polyoma virus middle 
T (pmt) antigen. This analysis was restricted to the /3-type 
PDGF receptor since the major mitogenic effect of PDGF 
in human fibroblasts is mediated via the /3-type receptor 
[12]. We report here that v-src transformation of NRK 
fibroblasts results in a reduction in the levels of PDGF 
receptor mRNA, with a consequent reduction in the 
amounts of PDGF receptor at the cell surface. Interest- 
ingly, PDGF receptor levels are not changed following pmt 
transformation. 
2. Materials and methods 
2.1. Materials 
PDGF (BB homodimer) and rabbit anti-PDGF receptor 
(/3 type) polyclonal antiserum (PDGFR-3 [13]) were gen- 
erous gifts from A. Thomasen (Amgen, Thousand Oaks, 
CA) and C.-H. Heldin (Ludwig Insitute, Uppsala, Sweden) 
respectively. 125I-Bolton and Hunter-labelled PDGF BB 
homodimer (1.13 × 10 6 cpm/pmol) was purchased from 
Amersham, Bucks., UK. 3,-[ 32 P]ATP and [32 P]orthophos- 
phate were from Bresatec, Adelaide, South Australia. Nor- 
mal rat kidney fibroblasts (NRK 49 F) were from the 
American Type Culture Collection, RockviUe, MD. The 
derivation by Bruce Mann (Ludwig Institute, Melbourne, 
Australia) of stable NRK transformants expressing either 
the pmt or the v-src oncogene, and the evidence that the 
proteins encoded by both oncogenes are active, has been 
presented previously [11]. Unless otherwise indicated v- 
src-NRK clone 1 was used for all experiments. 
2.2. Methods 
Binding assay. The protocol for measurement of PDGF 
receptor binding has been described in detail previously 
[14]. Briefly, cells were grown to confluence in 24-well 
plates, and serum starved overnight prior to assay. For 
duplicate binding assays, cells were incubated for 30 min 
at 37°C in 0.5 ml 1% bovine serum albumin in Dulbecco's 
modified Eagle's medium containing a fixed concentration 
of 125I-PDGF (50 pM) and increasing concentrations of
unlabelled PDGF (3 pM-800 pM). Non-specific binding 
was determined by addition of a 100-fold excess of unla- 
belled PDGF. Cells were rinsed twice with phosphate- 
buffered saline, lysed in 1 M NaOH, and transferred to 
y-counter tubes for counting of bound 125I-PDGF. Cell 
numbers in a duplicate well were determined by counting 
in a hemocytometer after trypsinization. 
In vitro kinase assay. Confluent cells were placed in 
Dulbecco's modified Eagle's medium without serum for 
20 h, after which PDGF-BB (100 ng/ml) or an equivalent 
volume of medium was added for 15 min. Crude mem- 
branes were prepared as described previously [11] and 
extracted for 20 min with NP 40 buffer (20 mM Tris, pH 
8.0, 150 mM NaCI, 1% NP40, 10 U/ml  aprotinin, 20/zM 
leupeptin, 100 /zM Na + orthovanadate, 2.5 mM EDTA, 
10 mM NaF). The crude membrane xtracts were cleared 
by centrifugation at4°C for 15 min, and immunoprecipita- 
tion was performed with an anti-PDGF /3-type receptor 
serum [13] at a 1:250 dilution. The immunoprecipitates 
were collected by adding protein-A Sepharose, and were 
washed three times with NP40 buffer and two times with 
kinase buffer (20 mM Hepes, pH 7.5, 10 mM MnC12, 100 
/xM sodium orthovanadate). Kinase activity was assayed 
in 50/zl of kinase buffer containing 10/xCi of [T-32p]ATP 
for 10 min at 25°C. Reactions were stopped by the addition 
of 50/zl sample buffer and boiled for 10 min. The proteins 
were separated by electrophoresis on a 10% sodium dode- 
cyl sulphate (SDS)-polyacrylamide g l and visualized by 
scanning with a phosphorimager (Molecular Dynamics, 
Sunnyvale, CA). 
Cell labelling with [32p]orthophosphate. Confluent 
NRK and v-src-NRK cells in 90-mm dishes were placed in 
serum-free Dulbecco's modified Eagle's medium for 20 h. 
The cells were washed three times with phosphate-free 
medium and labelled with 500 /zCi/ml [32p]orthophos- 
phate for 2 h at 37°C. The cells were then incubated with 
or without 100 ng/ml PDGF-BB for an additional 15 min 
before membrane xtracts were prepared as described 
above. The protein contents of the membrane extracts were 
determined by the Bradford method [15] and the same 
amount of protein from each cell line was used for im- 
munoprecipitation with anti-PDGF receptor antibody. The 
immunoprecipitates were analyzed on a 7.5% SDS-poly- 
acrylamide gel and visualized by scanning with a phospho- 
rimager. 
Immunoblotting. Confluent cells were placed in serum- 
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free Dulbecco's modified Eagle's medium for 20 h. The 
membrane pellets were prepared as described above and 
the protein contents were determined by the Bradford 
assay [15]. The pellets were extracted with 100 /zl sample 
buffer (95°C, 10 min) and centrifuged for 10 min at 
15 000 X g. Equivalent amounts of the supernatant protein 
were electrophoresed on 7.5% SDS-polyacrylamide g ls 
and electrophoretically transferred to an Immobilon 
poly(vinylidene difluoride) membrane (Millipore, Bedford, 
MA). The membrane was treated at room temperature with 
agitation for 1 h in blocking solution (PBS, 4% BSA, 
0.05% Tween 20), and washed twice for 5 min each in 
wash solution (PBS, 0.1% BSA, 0.02% Tween 20). The 
anti-PDGF receptor fl-type antibody was added at a 
1:10 000 dilution in wash solution and incubated overnight 
at 4°C with agitation. The membrane was washed 3 times 
for 7 min each in wash solution and incubated with goat 
anti-rabbit IgG(H + L)-horseradish peroxidase conjugate 
(Bio-Rad laboratories, Hercules, CA) at a 1:10 000 dilution 
in wash solution for 1 h at room temperature with agita- 
tion. The membrane wa:~ agitated (3 × 20 min) in wash 
solution, and receptor was detected by enhanced chemilu- 
minescence (Amersham, Bucks., UK) according to the 
manufacturer's instructions. 
PolyA+-mRNA isolation and Northern blot analysis. 
Cells were grown to confluence and placed in serum-free 
media overnight. Cells were homogenized in a solution 
containing 10 mM Tris-HCl (pH 7.4), 0.1 M NaC1, 1 mM 
EDTA, 200 /zg per ml proteinase K, and 0.5% SDS and 
incubated for 1 h at 37°C. mRNA was enriched by poly 
(A) ÷ selection on oligodeoxythymidylate cellulose [16] 
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Fig. 1. Comparison f 125I-PDGF binding to v-src-NRK and NRK cells. 
Binding of 125I-PDGF-BB (28250 cpm, 25 fmol) to 106 v-src-NRK (0)  
or NRK (©) fibroblasts was :measured in duplicate in the presence of
increasing concentrations of unlabelled PDGF (3 pM-800 pM) as de- 
scribed in Section 2. Data were fitted with the program LIGAND [18]. 
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Table 1 
PDGF Receptor levels on transformed NRK cells 
Cell line Surface PDGF K d (M) a 
receptors/cell a 
NRK 2.2.105 3.5.10 -9 
pmt-NRK 2.0.105 4.2.10-9 
v-src-NRK 2.9.104 8.2.10- 9 
a Calculated with the program taGAt,~ [18]. 
and precipitated with sodium acetate and ethanol. Then, 17 
/zg of polyA+-mRNA was denatured at 65°C in 2.2 M 
formaldehyde, 1 mM EDTA, 5 mM Na ÷ acetate, 20 mM 
Mops (pH 7.0; RNA buffer) in 50% (v /v)  formamide, 
fractionated electrophoretically on a 1% (w/v)  agarose gel 
in RNA buffer, and transferred onto a nylon membrane 
(GeneScreen, Du Pont, Boston, MA) with 10 × SSC (1.5 
M NaCI, 0.15 M Na ÷ citrate). The membrane was prehy- 
bridized at 42°C in the presence of 50% formamide (de- 
ionized), 1% dextran sulfate and 100 /.~g per ml denatured 
salmon sperm DNA for 4 h. The same solution was used 
for hybridization (42°C, overnight) except that salmon 
sperm DNA was omitted. The 32p-labelled probe, corre- 
sponding to the transmembrane, the juxtamembrane and 
the first tyrosine kinase segments of the human PDGF 
fl-type receptor [17] was denatured and added at a concen- 
tration of 2- 106 cpm per ml. The membrane was washed 
in 2 × SSC at room temperature for 10 min, then twice in 
2 × SSC, 1% SDS at 60°C for 20 min, and finally visual- 
ized by scanning with a phosphorimager. 
3. Results 
3.1. Levels of  PDGF receptor in transformed cells 
We have reported previously that PDGF-dependent 
autophosphorylation of the PDGF receptor in v-src-trans- 
formed NRK fibroblasts is profoundly suppressed [11]. To 
investigate the cause of this suppression we first measured 
cell surface binding of 125I-PDGF (Fig. 1, Table 1). The 
number of PDGF receptors on v-src-NRK cells was only 
13% of the number on NRK cells, while the affinity of the 
residual receptors was reduced only 2-fold. In contrast, the 
number of PDGF receptors on pmt-NRK cells was 90% of 
the number on NRK cells. The reduction in the number of 
receptors on v-src-NRK cells was confirmed by Western 
blotting equal amounts of membrane protein from v-src- 
NRK, pmt-NRK and NRK cells with an anti-PDGF recep- 
tor antibody (Fig. 2). Levels of PDGF receptor in the 
v-src-NRK cells were only 10% of the levels in NRK or 
pmt-NRK cells. The activity of the residual PDGF recep- 
tors in an autophosphorylation assay in vitro was then 
tested in immunoprecipitates prepared from v-src-NRK 
cells with antibodies to the PDGF receptor (Fig. 3). The 
levels of PDGF receptor autophosphorylation n immuno- 
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precipitates from unstimulated and stimulated v-src NRK 
cells were only 40% and 25%, respectively, of the levels 
observed in unstimulated and stimulated NRK cells. When 
corrected for the 7- to 10-fold reduction in PDGF receptor 
numbers in v-src-NRK cells, the specific autokinase activ- 
ity of the residual PDGF receptors was actually increased 
by v-src transformation. Moreover, the residual PDGF 
receptor in v-src-NRK cells still showed a 4.3-fold in- 
crease in autophosphorylation n response to PDGF, sug- 
gesting that the tyrosine kinase activity of the residual 
receptors could still be activated by PDGF binding. In 
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Fig. 3. Comparison of PDGF receptor kinase activity in NRK, pmt-NRK, 
and v-src-NRK cells. Confluent and serum starved ceils were incubated 
with (+)  or without ( - )  PDGF-BB (100 ng/ml)  for 15 min at 37°C. 
Membranes were prepared and extracted with detergent, and equivalent 
amounts of protein were incubated with an anti-PDGF receptor (fl-type) 
antiserum. The immunoprecipates were then autophosphorylated with 10 
~Ci 7-[32p]ATP for 10 rain at 25°C, and the phosphoproteins were 
separated by SDS-polyacrylamide g l electrophoresis and visualized and 
quantitated with a phosphorimager. The radioactivity associated with the 
PDGF receptor was expressed as a percentage of the value in stimulated 
NRK cells. These data were representative of 4 similar experiments. 
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Fig. 2. Comparison of PDGF receptor levels in NRK, pmt-NRK, and 
v-src-NRK cells by Western blotting. Membrane protein (30 txg) from 
each cell line was electrophoresed on a 7.5% SDS-polyacrylamide g l 
and transferred to an Immobilon membrane. The membrane was incu- 
bated with rabbit anti-PDGF receptor (/3-type) antiserum, washed and 
incubated with goat anti-rabbit IgG-horseradish peroxidase conjugate. 
Bound antibody was detected by enhanced chemiluminescence, andquan- 
titated with a phosphorimager. The sizes of molecular weight markers are 
given in kDa, and the position of the PDGF receptor is indicated. 
contrast, levels of PDGF receptor autophosphorylation were 
similar in immunoprecipitates prepared from pmt-NRK 
and NRK cells. 
3.2. Phosphorylation state of the PDGF receptor 
To determine whether the reduction in PDGF receptor 
levels was a consequence of autocrine PDGF production, 
v-src-NRK and NRK cells were labelled to equilibrium 
with [32p]orthophosphate andtreated with PDGF or buffer 
only. The PDGF receptor was isolated by immunoprecip- 
itation, and purified by electrophoresis on SDS-polyacryl- 
amide gels which were analysed with a phosphorimager 
(Fig. 4). The observation that phosphorylation f the PDGF 
receptor increased 15-fold in v-src-NRK cells compared 
with a 6-fold increase in NRK cells dearly established that 
the PDGF receptor was not maximally phosphorylated in 
the transformed cells, and hence suggested that significant 
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amounts of  PDGF were not secreted into the medium by 
the cells. In addition comparison of  the levels of  PDGF 
receptor phosphorylation i  v-s rc -NRK cells with the lev- 
els in NRK cells before (16-fold lower) and after (7-fold 
lower) PDGF stimulation yielded results which were con- 
sistent with the 7-fold decrease in PDGF receptor levels 
observed in a direct binding assay (Table 1). There is thus 
no evidence that the level of  phosphoamino acids in the 
unstimulated PDGF receptor is elevated in NRK fibrob- 
lasts fo l lowing v-src transformation. This result is clearly 
different from Rat-1 fibroblasts transfected with the human 
EGF receptor where expression of the v-src oncogene 
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Fig. 4. The PDGF receptor is not fully phosphorylated in v-src-NRK 
cells. Confluent and serum-free cells were labelled with 0.5 mCi [ 32 P]or- 
thophosphate p r ml for 2 h at 37°C. The cells were then incubated with 
(+) or without ( - )  100 ng/ml PDGF for 15 rain. Membranes were 
prepared and extracted with detergent and equal amounts of membrane 
extract were immunoprecipitated with anti-PDGF receptor antiserum. The 
immunoprecipitates were analyzed by electrophoresis on 7.5% SDS- 
polyacrylamide gels, and the PDGF receptor was visualized and quanti- 
tated by scanning with a phosphorimager. The radioactivity associated 
with the PDGF receptor was expressed as a percentage of the value for 
stimulated NRK cells. This experiment was performed only once because 
of the high levels of radioactivity (4 me i) required. 
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Fig. 5. Comparison of PDGF receptor mRNA levels in NRK, pmt-NRK, 
and v-src-NRK cells. PolyA+-mRNA (17 ~g) from NRK and pmt-NRK 
cells, and from three independent clones of v-src-transformed-NRK cells, 
was size fractionated on a 1% agarose gel and transferred onto a nylon 
membrane. The membrane was hybridized sequentially with [ 32 P]-labelled 
probes for the human fl-type PDGF receptor and for GAPDH. The 
radioactive bands were visualized and quantitated by scanning with a 
phosphorimager, and the values obtained after normalization for the 
variation in levels of GAPDH mRNA were expressed as a percentage of 
the value obtained for NRK cells. Sizes of RNA standards are indicated 
in kb. 
resulted in a 2.5-fold increase in the level of  phospho- 
amino acids in the unstimulated human EGF receptor [19]. 
3.3. Levels o f  PDGF receptor mRNA 
We next measured levels of  PDGF receptor mRNA in 
v-s rc -NRK cells by Northern blotting. In three indepen- 
dently isolated clones of  v-src-transformed NRK cells the 
amounts of  PDGF receptor mRNA were between 6 and 
13% of the amounts observed in the parent NRK cells 
(Fig. 5). In contrast, levels of  PDGF mRNA in pmt-NRK 
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cells were 75% of the levels in NRK cells. The reduction 
in mRNA levels did not appear to be a consequence of 
autocrine PDGF production, since treatment of NRK fi- 
broblasts with 100 ng/ml  PDGF-BB for 20 h before 
mRNA isolation did not result in any reduction in the 
levels of PDGF receptor mRNA (data not shown). 
4. Discussion 
Although there is general agreement in the literature 
that the EGF receptor in v-src- t ransformed mouse and rat 
fibroblasts is down-regulated, the exact mechanism is con- 
troversial. Gray and Macara [6] reported that the number of 
EGF receptors was unchanged, but that their affinity for 
EGF was decreased 10-fold following v-src transforma- 
tion. In contrast, Decker [4], and Weber and coworkers [5] 
have reported that the number of EGF binding sites in 
v-src- t ransformed rat fibroblasts is less than 10% of the 
number in the parent cells, and that this decrease is due to 
a decrease in EGF receptor protein [5], which in turn is due 
to a decrease in EGF receptor mRNA [3]. 
When we observed that PDGF-dependent autophospho- 
rylation of the PDGF receptor was significantly reduced in 
NRK fibroblasts transformed with the v-src oncogene [11], 
we therefore measured the number and affinity of PDGF 
binding sites on the cell surface. The results clearly indi- 
cated that the number of PDGF binding sites was reduced 
following transformation, but that the affinity of the resid- 
ual PDGF receptors was unchanged. No such decrease in 
PDGF receptor numbers was observed in NRK fibroblasts 
transformed by the pmt oncogene. Measurements of the 
levels of PDGF receptor protein directly by Western blot- 
ting or indirectly by immunoprecipitation a d autophos- 
phorylation were in complete agreement with the results of 
the binding studies. Northern blotting of poly-A ÷ mRNA 
prepared from v-s rc -NRK,  pmt-NRK and NRK cells with 
PDGF receptor probes revealed, in the v-s rc -NRK cells 
only, a decrease in PDGF receptor mRNA which closely 
paralleled the decrease in PDGF receptor protein. Further- 
more a similar reduction in PDGF receptor mRNA levels 
was observed with three independently isolated clones of 
v-src- t ransformed NRK cells, indicating that the reduction 
was not caused by a spontaneous mutation occurring after 
the transformation event. We conclude that transformation 
of NRK fibroblasts by the v-src oncogene results in a 
reduction in the levels of PDGF receptor mRNA, which 
ultimately leads to a reduction in the PDGF binding sites 
at the cell surface. 
Although we have not directly measured PDGF levels 
in media conditioned by v-s rc -NRK cells, two observa- 
tions suggest that the reduction in cell surface PDGF 
receptors is not caused by increased receptor internaliza- 
tion and degradation following binding of autocrine PDGF. 
Firstly treatment of untransformed NRK fibroblasts with 
100 ng/ml  PDGF-BB for 20 h did not alter PDGF recep- 
tor mRNA levels. This observation is consistent with the 
data of Heldin and co-workers who found that following 
treatment of untransformed human foreskin fibroblasts with 
100 ng/ml  PDGF-BB the levels of PDGF receptor mRNA 
actually increased 4-fold at 8 h and returned to normal at 
24 h, while levels of cell surface PDGF binding decreased 
3-fold by 1 h and remained at that level for 24 h [20]. 
Hence the observed 7-fold reduction in PDGF receptor 
mRNA levels following v-src transformation is not consis- 
tent with the effects of autocrine PDGF production pre- 
dicted from the effects observed with exogenous PDGF. 
Secondly, when v-s rc -NRK cells which had been labelled 
with [32 P]orthophosphate w re stimulated with PDGF, the 
fold increase in PDGF receptor autophosphorylation was 
greater than in untransformed NRK cells (Fig. 4). If any 
autocrine PDGF had been present he basal level of PDGF 
receptor autophosphorylation should have been increased, 
and hence the fold increase observed following addition of 
PDGF would have been expected to be reduced in the 
transformed cells. We conclude that production of au- 
tocrine PDGF by v-src- t ransformed NRK cells does not 
contribute significantly to the observed reduction in cell 
surface PDGF receptors. 
Paradoxically the reduction in cell surface PDGF recep- 
tors is probably not the cause of the cells' failure to 
respond mitogenically to PDGF [11]. Our results clearly 
show that the transformed cells still possess an average of 
29 000 binding sites each, and that the ability of these 
residual receptors to autophosphorylate in response to 
PDGF is undiminished. Moreover, Racker and co-workers 
have previously demonstrated that phospholipase C-media- 
ted phosphoinositide hydrolysis in v-src- t ransformed mouse 
3T3 cells is still activated by PDGF [10]. A more likely 
explanation than the reduction in PDGF binding sites for 
the lack of a mitogenic response is that the cells are 
proliferating at a maximal rate because the v-src protein 
stimulates a component in the signalling cascade down- 
stream from the PDGF receptor. 
The effects of v-src transformation  the PDGF recep- 
tor are clearly different from the effects of transformation 
by the v-ras oncogene or by the middle T antigen of 
polyoma virus. Mouse 3T3 fibroblasts transformed with 
the v-ras oncogene have undiminished levels of PDGF 
receptor [8-10]. However, the autophosphorylating ability 
of the PDGF receptor is substantially reduced by an in- 
hibitory factor present in the membranes of the v-ras-trans- 
formed cells [8], and there is no activation of phospho- 
lipase C-mediated phosphoinositide hydrolysis [10] or in- 
duction of c-myc and c-fos expression in response to 
PDGF [9]. In the case of pmt-NRK cells, levels of PDGF 
binding are only slightly lower than in NRK cells (Table 
1), the PDGF receptor is still autophosphorylated in re- 
sponse to PDGF, and a mitogenic response to PDGF is still 
observed [11]. The differences between pmt-NRK and 
v-s rc -NRK cells are particularly surprising because pmt 
transformation is thought to be a consequence of the 
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activation of c -s rc  following binding of the middle T 
antigen [21] and hence imply that the signal transduction 
pathways form c -s rc  and v . . s rc  are not identical. In conclu- 
sion transformation of NRK fibroblasts by the v-s rc  onco- 
gene differs from transformation by the v- ras  or pmt 
oncogenes in that levels of PDGF receptor mRNA are 
reduced with a consequent decrease in the numbers of 
PDGF receptors on the cell surface. 
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